TARGETING CANCER STEM CELLS WITH A NOVEL GLYCOLYTIC INHIBITOR TO OVERCOME METASTASIS AND CHEMORESISTANCE IN SMALL CELL LUNG CANCER

$159,000FY2018Department of the ArmyDOD

Mayo Clinic, Rochester MN

Investigators